The integration of two novel technologies creates a simple and functionally closed solution for upfront cell washing, media exchange, or culture harvest. Decouple your wash and harvest steps from your cell culture vessel to free up precious capital equipment and clean room space.

Lovo Cell Processing System
Lovo delivers automated, functionally closed cell processing through spinning membrane filtration. Whether you're working with millions or billions of cells, in 10mL or 22L, Lovo can adapt with you to easily scale your process, from Phase 1 through Commercialization. Lovo's intuitive operation simplifies your processes while minimizing operator interaction allowing you to easily configure parameters and create protocols for different cells, different applications, and different trials — all on the same platform. Applications include immunomagnetic selection prep, fresh leukapheresis wash, culture harvest and media exchange, and thawed wash and DMSO removal.

G-Rex Cell Culture Device
Wilson Wolf developed “G-Rex” technology to create the most practical cell production platform possible for Adoptive Cell Therapy. G-Rex devices save material and labor while simultaneously shortening production time. Stop by our booth to learn about our scale up and scale out plans in addition to customized options for specialized requirements. Providing virtually unlimited oxygen and nutrients on demand is particularly beneficial for the culture of non-adherent cells when compared to prior methods, such as plates, flasks, bags, and RM bags or other bioreactors. Advantages include:
- Technician interaction is greatly reduced; these devices reach maximum density without feeding or other interventions.
- More cells in less space. Leaves more room in your incubator for other cultures.
- Simplicity. No need to constantly feed and split cultures to new devices as your culture scales.
- Saves money. Requires fewer devices, reduces use of expensive GMP space, and far less labor.

*The LOVO Cell Processing system is for laboratory use only. Unless the user has obtained advance clearance or approval from the appropriate regulatory agency, cells processed on this system are not intended for diagnostic purposes, direct transfusion, or for use in the production of therapeutic products or vaccines for clinical use. For applications requiring regulatory clearance or approval, users may request the required LOVO technical documentation from Fresenius Kabi to support their submissions.